Wanda, one of healthcare tech investor NetScientific plc’s (LON:NSCI) core investments, has formed a scientific advisory board to guide the management team.
The board will include distinguished physicians, health economics scientists, and technologists committed to advancing clinical outcomes for individuals with chronic disease.
Wanda has developed a way to digitally monitor people with congestive heart failure and other chronic conditions.
Last month, it announced the launch of a software platform to improve cancer care in collaboration with leading US hospital group Dignity Health.
Francois Martelet, NetScientific's chief executive, said: "Wanda's technology has broad potential to simplify and improve the lives of people confronted with chronic conditions and, in the near term, to help patients with congestive heart failure and their physicians to monitor risk and predict and prevent readmission to hospital.
“The calibre of the new SAB members is testament to the quality of the Wanda platform and we look forward to their input as Wanda develops into a world-leading digital health business."
Members of the new Wanda board include: Constanzo DiPerna, - medical director of Dignity Health Cancer Institute of Greater Sacramento; Clyde Wesp, executive clinical strategist at Jacobus Consulting; Janki Shah, founder and director of the UCLA Northwest Valley Women's Heart Health Program and Jeff Moreland, CEO and chief patient officer for Patient Engagement Advisors (PEA).